HEADER SIGNALING PROTEIN 25-FEB-17 5X7D TITLE STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO CARAZOLOL AND AN TITLE 2 INTRACELLULAR ALLOSTERIC ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHIMERA PROTEIN OF BETA-2 ADRENERGIC RECEPTOR AND LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP P07550 RESIDUES 1-230, UNP D9IEF7 RESIDUES 2-162, UNP COMPND 5 P07550 RESIDUES 264-365; COMPND 6 SYNONYM: BETA-2 ADRENORECEPTOR,BETA-2 ADRENOCEPTOR; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: ADRB2, ADRB2R, B2AR, E, T4TP126; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PVL1392 KEYWDS GPCR, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.LIU,S.AHN,A.W.KAHSAI,K.-C.MENG,N.R.LATORRACA,B.PANI, AUTHOR 2 A.J.VENKATAKRISHNAN,A.MASOUDI,W.I.WEIS,R.O.DROR,X.CHEN, AUTHOR 3 R.J.LEFKOWITZ,B.K.KOBILKA REVDAT 6 06-NOV-24 5X7D 1 REMARK REVDAT 5 18-OCT-23 5X7D 1 REMARK REVDAT 4 12-OCT-22 5X7D 1 REMARK REVDAT 3 06-SEP-17 5X7D 1 JRNL REVDAT 2 30-AUG-17 5X7D 1 JRNL REVDAT 1 16-AUG-17 5X7D 0 JRNL AUTH X.LIU,S.AHN,A.W.KAHSAI,K.C.MENG,N.R.LATORRACA,B.PANI, JRNL AUTH 2 A.J.VENKATAKRISHNAN,A.MASOUDI,W.I.WEIS,R.O.DROR,X.CHEN, JRNL AUTH 3 R.J.LEFKOWITZ,B.K.KOBILKA JRNL TITL MECHANISM OF INTRACELLULAR ALLOSTERIC BETA 2AR ANTAGONIST JRNL TITL 2 REVEALED BY X-RAY CRYSTAL STRUCTURE. JRNL REF NATURE V. 548 480 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28813418 JRNL DOI 10.1038/NATURE23652 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_2650: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.9 REMARK 3 NUMBER OF REFLECTIONS : 12917 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1290 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.9771 - 5.5868 0.98 1608 182 0.1890 0.2425 REMARK 3 2 5.5868 - 4.4505 1.00 1545 172 0.2107 0.2604 REMARK 3 3 4.4505 - 3.8927 1.00 1539 170 0.2032 0.2175 REMARK 3 4 3.8927 - 3.5389 1.00 1517 171 0.2376 0.3031 REMARK 3 5 3.5389 - 3.2864 1.00 1497 163 0.2693 0.3166 REMARK 3 6 3.2864 - 3.0934 0.99 1473 173 0.2915 0.3252 REMARK 3 7 3.0934 - 2.9390 0.84 1265 123 0.2756 0.3532 REMARK 3 8 2.9390 - 2.8114 0.58 868 100 0.2865 0.3671 REMARK 3 9 2.8114 - 2.7035 0.22 315 36 0.2899 0.3288 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3755 REMARK 3 ANGLE : 0.774 5108 REMARK 3 CHIRALITY : 0.442 589 REMARK 3 PLANARITY : 0.009 611 REMARK 3 DIHEDRAL : 15.108 2158 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5X7D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1300003040. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 78 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12966 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.0 REMARK 200 DATA REDUNDANCY : 12.20 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 13.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.840 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2RH1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, PH 7.5, 30% -37.5% REMARK 280 PEG400, 400 MM NH4F, 6% 1,4-BUTANEDIOL, 1 MM CMPD-15PA AND 1% REMARK 280 DMSO., LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.23000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.70500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.85500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.70500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.23000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.85500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -6 REMARK 465 TYR A -5 REMARK 465 LYS A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 GLN A 3 REMARK 465 PRO A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 PHE A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASN A 15 REMARK 465 ARG A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 ALA A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 HIS A 22 REMARK 465 ASP A 23 REMARK 465 VAL A 24 REMARK 465 THR A 25 REMARK 465 GLN A 26 REMARK 465 GLN A 27 REMARK 465 ARG A 28 REMARK 465 ASP A 29 REMARK 465 GLU A 30 REMARK 465 ARG A 343 REMARK 465 ARG A 344 REMARK 465 SER A 345 REMARK 465 SER A 346 REMARK 465 LEU A 347 REMARK 465 LYS A 348 REMARK 465 ALA A 349 REMARK 465 TYR A 350 REMARK 465 GLY A 351 REMARK 465 ASN A 352 REMARK 465 GLY A 353 REMARK 465 TYR A 354 REMARK 465 SER A 355 REMARK 465 SER A 356 REMARK 465 ASN A 357 REMARK 465 GLY A 358 REMARK 465 ASN A 359 REMARK 465 THR A 360 REMARK 465 GLY A 361 REMARK 465 GLU A 362 REMARK 465 GLN A 363 REMARK 465 SER A 364 REMARK 465 GLY A 365 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 304 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 66 O2S EPE A 1201 2.03 REMARK 500 NZ LYS A 140 OE1 GLN A 229 2.04 REMARK 500 OD1 ASP A 1072 O HOH A 1301 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 EPE A 1201 REMARK 610 EPE A 1202 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EPE A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EPE A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CLR A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CLR A 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8VS A 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CAU A 1206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BU1 A 1207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACM A 1208 DBREF 5X7D A 1 230 UNP P07550 ADRB2_HUMAN 1 230 DBREF 5X7D A 1002 263 UNP D9IEF7 D9IEF7_BPT4 2 162 DBREF 5X7D A 264 365 UNP P07550 ADRB2_HUMAN 264 365 SEQADV 5X7D ASP A -6 UNP P07550 EXPRESSION TAG SEQADV 5X7D TYR A -5 UNP P07550 EXPRESSION TAG SEQADV 5X7D LYS A -4 UNP P07550 EXPRESSION TAG SEQADV 5X7D ASP A -3 UNP P07550 EXPRESSION TAG SEQADV 5X7D ASP A -2 UNP P07550 EXPRESSION TAG SEQADV 5X7D ASP A -1 UNP P07550 EXPRESSION TAG SEQADV 5X7D ALA A 0 UNP P07550 EXPRESSION TAG SEQADV 5X7D ARG A 16 UNP P07550 GLY 16 CONFLICT SEQADV 5X7D GLN A 27 UNP P07550 GLU 27 CONFLICT SEQADV 5X7D GLU A 187 UNP P07550 ASN 187 ENGINEERED MUTATION SEQADV 5X7D THR A 1054 UNP D9IEF7 CYS 54 ENGINEERED MUTATION SEQADV 5X7D ALA A 1097 UNP D9IEF7 CYS 97 ENGINEERED MUTATION SEQRES 1 A 500 ASP TYR LYS ASP ASP ASP ALA MET GLY GLN PRO GLY ASN SEQRES 2 A 500 GLY SER ALA PHE LEU LEU ALA PRO ASN ARG SER HIS ALA SEQRES 3 A 500 PRO ASP HIS ASP VAL THR GLN GLN ARG ASP GLU VAL TRP SEQRES 4 A 500 VAL VAL GLY MET GLY ILE VAL MET SER LEU ILE VAL LEU SEQRES 5 A 500 ALA ILE VAL PHE GLY ASN VAL LEU VAL ILE THR ALA ILE SEQRES 6 A 500 ALA LYS PHE GLU ARG LEU GLN THR VAL THR ASN TYR PHE SEQRES 7 A 500 ILE THR SER LEU ALA CYS ALA ASP LEU VAL MET GLY LEU SEQRES 8 A 500 ALA VAL VAL PRO PHE GLY ALA ALA HIS ILE LEU MET LYS SEQRES 9 A 500 MET TRP THR PHE GLY ASN PHE TRP CYS GLU PHE TRP THR SEQRES 10 A 500 SER ILE ASP VAL LEU CYS VAL THR ALA SER ILE GLU THR SEQRES 11 A 500 LEU CYS VAL ILE ALA VAL ASP ARG TYR PHE ALA ILE THR SEQRES 12 A 500 SER PRO PHE LYS TYR GLN SER LEU LEU THR LYS ASN LYS SEQRES 13 A 500 ALA ARG VAL ILE ILE LEU MET VAL TRP ILE VAL SER GLY SEQRES 14 A 500 LEU THR SER PHE LEU PRO ILE GLN MET HIS TRP TYR ARG SEQRES 15 A 500 ALA THR HIS GLN GLU ALA ILE ASN CYS TYR ALA GLU GLU SEQRES 16 A 500 THR CYS CYS ASP PHE PHE THR ASN GLN ALA TYR ALA ILE SEQRES 17 A 500 ALA SER SER ILE VAL SER PHE TYR VAL PRO LEU VAL ILE SEQRES 18 A 500 MET VAL PHE VAL TYR SER ARG VAL PHE GLN GLU ALA LYS SEQRES 19 A 500 ARG GLN LEU ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 20 A 500 GLY LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 21 A 500 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 22 A 500 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 23 A 500 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 24 A 500 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 25 A 500 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 26 A 500 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 27 A 500 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 28 A 500 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 29 A 500 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 30 A 500 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 31 A 500 THR GLY THR TRP ASP ALA TYR LYS PHE CYS LEU LYS GLU SEQRES 32 A 500 HIS LYS ALA LEU LYS THR LEU GLY ILE ILE MET GLY THR SEQRES 33 A 500 PHE THR LEU CYS TRP LEU PRO PHE PHE ILE VAL ASN ILE SEQRES 34 A 500 VAL HIS VAL ILE GLN ASP ASN LEU ILE ARG LYS GLU VAL SEQRES 35 A 500 TYR ILE LEU LEU ASN TRP ILE GLY TYR VAL ASN SER GLY SEQRES 36 A 500 PHE ASN PRO LEU ILE TYR CYS ARG SER PRO ASP PHE ARG SEQRES 37 A 500 ILE ALA PHE GLN GLU LEU LEU CYS LEU ARG ARG SER SER SEQRES 38 A 500 LEU LYS ALA TYR GLY ASN GLY TYR SER SER ASN GLY ASN SEQRES 39 A 500 THR GLY GLU GLN SER GLY HET EPE A1201 5 HET EPE A1202 5 HET CLR A1203 28 HET CLR A1204 28 HET 8VS A1205 43 HET CAU A1206 22 HET BU1 A1207 6 HET ACM A1208 4 HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM CLR CHOLESTEROL HETNAM 8VS 4-CARBAMOYL-N-[(2R)-2-CYCLOHEXYL-2-PHENYLACETYL]-L- HETNAM 2 8VS PHENYLALANYL-3-BROMO-N-METHYL-L-PHENYLALANINAMIDE HETNAM CAU (2S)-1-(9H-CARBAZOL-4-YLOXY)-3-(ISOPROPYLAMINO)PROPAN- HETNAM 2 CAU 2-OL HETNAM BU1 1,4-BUTANEDIOL HETNAM ACM ACETAMIDE HETSYN EPE HEPES HETSYN CAU (S)-CARAZOLOL FORMUL 2 EPE 2(C8 H18 N2 O4 S) FORMUL 4 CLR 2(C27 H46 O) FORMUL 6 8VS C34 H39 BR N4 O4 FORMUL 7 CAU C18 H22 N2 O2 FORMUL 8 BU1 C4 H10 O2 FORMUL 9 ACM C2 H5 N O FORMUL 10 HOH *5(H2 O) HELIX 1 AA1 VAL A 33 PHE A 61 1 29 HELIX 2 AA2 GLU A 62 GLN A 65 5 4 HELIX 3 AA3 THR A 66 VAL A 86 1 21 HELIX 4 AA4 VAL A 86 MET A 96 1 11 HELIX 5 AA5 PHE A 101 THR A 136 1 36 HELIX 6 AA6 THR A 146 MET A 171 1 26 HELIX 7 AA7 HIS A 178 GLU A 187 1 10 HELIX 8 AA8 ASN A 196 PHE A 208 1 13 HELIX 9 AA9 PHE A 208 GLN A 229 1 22 HELIX 10 AB1 ASN A 1002 ASP A 1010 1 9 HELIX 11 AB2 SER A 1038 GLY A 1051 1 14 HELIX 12 AB3 THR A 1059 ASN A 1081 1 23 HELIX 13 AB4 LYS A 1083 SER A 1090 1 8 HELIX 14 AB5 ASP A 1092 GLY A 1107 1 16 HELIX 15 AB6 GLY A 1107 ALA A 1112 1 6 HELIX 16 AB7 PHE A 1114 GLN A 1123 1 10 HELIX 17 AB8 ARG A 1125 LYS A 1135 1 11 HELIX 18 AB9 SER A 1136 THR A 1142 1 7 HELIX 19 AC1 THR A 1142 GLY A 1156 1 15 HELIX 20 AC2 TRP A 1158 LYS A 263 5 5 HELIX 21 AC3 LEU A 266 GLN A 299 1 34 HELIX 22 AC4 ARG A 304 VAL A 317 1 14 HELIX 23 AC5 GLY A 320 TYR A 326 1 7 HELIX 24 AC6 SER A 329 LEU A 340 1 12 SHEET 1 AA1 3 ARG A1014 LYS A1019 0 SHEET 2 AA1 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 AA1 3 HIS A1031 THR A1034 -1 O HIS A1031 N ILE A1027 SSBOND 1 CYS A 106 CYS A 191 1555 1555 2.01 SSBOND 2 CYS A 184 CYS A 190 1555 1555 2.04 LINK SG CYS A 265 C2 ACM A1208 1555 1555 1.61 SITE 1 AC1 7 THR A 66 VAL A 67 THR A 68 ARG A 131 SITE 2 AC1 7 TYR A 141 GLN A 142 SER A 143 SITE 1 AC2 5 PHE A 264 LYS A 270 LYS A 273 ARG A 328 SITE 2 AC2 5 ACM A1208 SITE 1 AC3 3 ILE A 55 LEU A 80 CLR A1204 SITE 1 AC4 7 THR A 73 CYS A 77 VAL A 81 ILE A 112 SITE 2 AC4 7 ILE A 154 LEU A 155 CLR A1203 SITE 1 AC5 15 VAL A 54 ILE A 58 ARG A 63 LEU A 64 SITE 2 AC5 15 ASN A 69 LYS A 267 LYS A 270 ALA A 271 SITE 3 AC5 15 THR A 274 LEU A 275 TYR A 326 ARG A 328 SITE 4 AC5 15 SER A 329 ASP A 331 PHE A 332 SITE 1 AC6 9 ASP A 113 VAL A 114 PHE A 193 SER A 203 SITE 2 AC6 9 TRP A 286 PHE A 290 ASN A 293 TYR A 308 SITE 3 AC6 9 ASN A 312 SITE 1 AC7 5 PHE A 223 LYS A 227 LYS A 263 PHE A 264 SITE 2 AC7 5 HIS A 269 SITE 1 AC8 3 PHE A 264 CYS A 265 EPE A1202 CRYST1 40.460 75.710 173.410 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024716 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013208 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005767 0.00000